NYSE · IH
iHuman financials
$1.14−0.87%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $115.3M | $126.3M | $143.8M | $142.9M | $944.7M | $531.9M |
| Gross profit | $78.3M | $87.7M | $101.9M | $100.2M | $660.6M | $365.4M |
| Gross margin | 67.9% | 69.4% | 70.8% | 70.1% | 69.9% | 68.7% |
| Operating income | $9.5M | $9.9M | $22.6M | $16.2M | -$54.2M | -$44.5M |
| Net income | $13.6M | $13.5M | $25.6M | $15.9M | -$37.1M | -$48.3M |
| Net margin | 11.8% | 10.7% | 17.8% | 11.1% | −3.9% | −9.1% |
| Diluted EPS | $0.05 | $0.05 | $0.09 | $0.06 | $-0.14 | $-0.21 |
| EBITDA | $10.6M | $11.7M | $24.2M | $17.7M | -$47.8M | -$41.6M |
| Operating cash flow | $7.3M | $8.0M | $24.3M | $27.3M | $38.2M | $223.0M |
| Free cash flow | $6.6M | $7.0M | $23.4M | $26.4M | $5.9M | $207.1M |
| Diluted shares | 267.6M | 271.2M | 273.8M | 270.2M | 266.6M | 226.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $164.5M | $153.9M | $171.5M | $1.05B | $855.4M | $861.7M |
| Short-term investments | $0.00 | $6.2M | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $195.6M | $194.5M | $204.9M | $1.33B | $1.10B | $1.05B |
| Total liabilities | $53.3M | $62.9M | $69.6M | $563.9M | $492.5M | $404.3M |
| Shareholders' equity | $142.2M | $131.6M | $135.3M | $769.5M | $608.4M | $642.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology